will be the subject of the joint-session organized by the Computer and
Telecommunications Law Commission, the European Union law Commission, the Intellectual Property Commission and the Privacy and Rights of the Digital Person Commission We are living in the digital age, in which data about us and our lives has become, according to your favorite metaphor, the new currency, the new oil or even the new soil. Such data is being recorded, stored and exploited by third parties and governments. Do you own your data? To what degree should you be entitled to keep it private, to control its use, or even to make it disappear. The full day program will take place on November 1 st from 9-12.30h and 14-17.30h in the Auditorium and will be divided in four different parts, as follows: PART I Current Laws Moderated by Marc Gallardo
9:00 10.30 Current EU Regime Marc Gallardo Privacy in the USA Rosemary Ring Data Protection Laws in India and Asia (I) Vipul Maheshwari Data Protection in Hong Kong and Asia (II) Angus Forsyth The Berlin Court of Appeal ruling in the Facebooks Friend Finder case Thomas Kritter Q&A COFFEE BREAK PART II The position of Lawyers Moderated by Bruce Landay
10:45 12:30 Client confidentiality and data privacy / cyber security Brad Richards Special rules for lawyers handling personal data Virginie Bensoussan The use of data as evidence in litigation Francisco Ramos Romeu and Gavin Llewellyn Security measures to protect personal data Phil Beckett Q&A 12:30 LUNCH
PART III Use of Data and Areas of Controversy Moderated by Ian de Freitas
14:00 15:45 The Internet of Things Alain Bensoussan Big data and Profiling Victor Rosell and Alain Grosjean The right to be forgotten / ownership and control of published information Rany Sader Contactless Payments Elisabeth Thole Q&A COFFEE BREAK PART IV The Future Moderated by Enrica Senini
16:00 17:30 EU Reforms: General overview International Data Transfers
Carlo Piltz Jean Franois Henrotte USA Reforms Rosemary Ring Privacy by Design and by Default Sebastien Fanti Does Anybody Care Mark Reutter Q&A END